Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance.

BACKGROUND Incident and prevalent (I&P) rates in dialysis end-stage renal disease (ESRD) patients in Taiwan increased rapidly following the launch of National Health Insurance (NHI) in 1995. Our aim was to explore the impact of NHI on the status and trends of ESRD epidemiology in Taiwan. METHODS This study was conducted using retrospective cohort analysis of data collected from the Taiwan national dialysis registry. RESULTS From 1990 to 2001, I&P rates of ESRD patients increased 2.6 times from 126 to 331 per million populations (pmp) and 3.46 times from 382 to 1322 pmp, respectively. Increasing ESRD was seen in patients who were middle-aged, elderly and who had diabetic nephropathy as their primary renal disease. The mean age of I&P patients increased by 7.2 years and 7.1 years, respectively. All of these parameters increased markedly in 1995, the year of NHI implementation. First-year mortality decreased to 7.8 per 1000 patient-months in 1994, and then increased to 18.0 in 2001. The cumulative survival rate of the elderly subgroup (age >65) in the incident 1990-1994 cohort was greater than in the 1995-1999 cohort. These data indicated that NHI implementation significantly influenced the inflow and the mortality of ESRD patients. CONCLUSION In addition to presenting ESRD epidemiology in Taiwan, this study demonstrated that NHI implementation stimulated the growth of treated ESRD populations. Preventive plans mounted against chronic kidney diseases will be essential to reduce the growth of ESRD patient numbers and consequent economic burdens.

[1]  H. Hsu,et al.  Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  Michael M. Davis,et al.  National health insurance. , 1949, Scientific American.

[3]  Simona Gioberge,et al.  ESRD patients in 2001: global overview of patients, treatment modalities and development trends. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  R. Wolfe,et al.  Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2003, Journal of the American Society of Nephrology : JASN.

[5]  K. Kikuchi,et al.  Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  G. Russ,et al.  Burden of end-stage renal disease among indigenous peoples in Australia and New Zealand. , 2003, Kidney international. Supplement.

[7]  S. Lee,et al.  Effects of global budgeting on the distribution of dentists and use of dental care in Taiwan. , 2004, Health services research.

[8]  H. Naito.  The Japanese Health-Care System and Reimbursement for Dialysis , 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[9]  O. Ayodele,et al.  The global burden of chronic kidney disease and the way forward. , 2005, Ethnicity & disease.

[10]  S. Nakai,et al.  Current status of renal replacement therapy in Japan: results of the annual survey of the Japanese Society for Dialysis Therapy. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  M. Wiedemann,et al.  Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  T. Tai,et al.  The status of diabetes control in Asia—a cross‐sectional survey of 24 317 patients with diabetes mellitus in 1998 , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[13]  A. Nissenson.  Restructuring the ESRD payment system in the United States. , 2004, Kidney international.

[14]  Lysaght Mj,et al.  Maintenance Dialysis Population Dynamics: Current Trends and Long-Term Implications , 2002 .

[15]  R. Barsoum.  Overview: end-stage renal disease in the developing world. , 2002, Artificial organs.

[16]  P. Roderick,et al.  Social deprivation and survival on renal replacement therapy in England and Wales. , 2006, Kidney international.

[17]  F. Dekker,et al.  Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  A. Collins,et al.  Projecting the number of patients with end-stage renal disease in the United States to the year 2015. , 2005, Journal of the American Society of Nephrology : JASN.

[19]  W. Hörl,et al.  Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: access to ESRD treatments. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  Kuan‐Hsing Chen,et al.  Aristolochic acid-related nephropathy associated with the popular Chinese herb Xi Xin. , 2006, Journal of nephrology.

[21]  T. Tai,et al.  Epidemiologic study of type 2 diabetes in Taiwan. , 2000, Diabetes research and clinical practice.

[22]  P. Roderick,et al.  Exploring the differences in epidemiology of treated ESRD between Germany and England and Wales. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  M. Dichgans.  CADASIL: A Monogenic Condition Causing Stroke and Subcortical Vascular Dementia , 2002, Cerebrovascular Diseases.

[24]  T. Chiang,et al.  Taiwan's 1995 health care reform. , 1997, Health policy.

[25]  E. Friedman.  Renal replacement therapy in Japan: better outcome than in the USA , 1996 .

[26]  Hideto Takahashi,et al.  Age distribution and yearly changes in the incidence of ESRD in Japan. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  S. Nakai,et al.  Nephrology Dialysis Transplantation Survival in Long-term Haemodialysis Patients: Results from the Annual Survey of the Japanese Society for Dialysis Therapy , 2022 .

[28]  E. Vittinghoff,et al.  Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. , 2003, Journal of the American Society of Nephrology : JASN.

[29]  R. Wolfe,et al.  Excerpts from United States Renal Data System 1995 Annual Data Report. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.